Twist Bioscience (TWST) Change in Accured Expenses (2017 - 2026)

Twist Bioscience (TWST) has reported Change in Accured Expenses for 10 consecutive years, with $2.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Accured Expenses fell 83.72% year-over-year to $2.9 million in Q2 2026; TTM through Jun 2026 was $23.4 million, a 115.16% increase from a year earlier, with the FY2025 full-year figure at $6.6 million, down 16.04% from the prior year.
• Change in Accured Expenses was $2.9 million for Q2 2026 at Twist Bioscience, down from $35.2 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $35.2 million in Q1 2026 and troughed at -$12.9 million in Q3 2022.
• A 5-year average of $2.2 million and a median of $2.0 million in 2024 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses sank 561.59% in 2022 and surged 1003.67% in 2026, its largest moves.
• Over 5 years, Change in Accured Expenses stood at -$3.7 million in 2022, then sank by 36.65% to -$5.1 million in 2023, then plunged by 133.36% to -$11.8 million in 2024, then dropped by 4.95% to -$12.4 million in 2025, then jumped by 123.0% to $2.9 million in 2026.
• The last three Change in Accured Expenses figures came in at $2.9 million (Q2 2026), $35.2 million (Q1 2026), and -$12.4 million (Q4 2025), per Business Quant data.